{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:57:53Z","timestamp":1793228273235,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS406"],"award-info":[{"award-number":["DS406"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Inflamm"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The differences between adults and children in inflammatory bowel disease (IBD) phenotype, severity, complications, co-morbidities, and response to the therapy resulted in the extraction of paediatric IBD. It has been revealed that the substantial role in the development of IBD in children under 6\u2009years of age plays a single genetic mutation (monogenic IBD). On the other hand, in older children and adolescents IBD is usually associated with number of interactions between susceptibility loci (polygenic IBD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>Until now there have been described about 60 monogenic defects which affect the variety of immune mechanisms in IBD pathogenesis including epithelial barrier, function of neutrophil granulocytes and phagocytes, T- and B-cell selection and activation, immune inhibitory mechanisms, or apoptosis. Il-10 is an anti-inflammatory cytokine which modulates innate and adaptive immunity affecting expression of pro-inflammatory molecules and function of the variety of immune cells. Patients with identified defects in Il-10 pathway manifest with life-threating colitis with perianal lesions which occurs within first months of life. Allogenic hematopoietic stem cell transplantation is curative therapy in children with Il-10 signalling defects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Clinical awareness of Il-10 signalling defects enables early recognition and prompt management of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12950-021-00279-3","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T13:03:30Z","timestamp":1615381410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-2197","authenticated-orcid":false,"given":"Paulina","family":"Krawiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Paw\u0142owska-Kamieniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Pac-Ko\u017cuchowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"1","key":"279_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91\u20139. https:\/\/doi.org\/10.3748\/wjg.v20.i1.91.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"279_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","volume":"147","author":"HH Uhlig","year":"2014","unstructured":"Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990\u20131007.e3. https:\/\/doi.org\/10.1053\/j.gastro.2014.07.023.","journal-title":"Gastroenterology"},{"issue":"3","key":"279_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000320393","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS. Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig Dis. 2010;28(3):395\u2013405. https:\/\/doi.org\/10.1159\/000320393.","journal-title":"Dig Dis"},{"issue":"5","key":"279_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/MOP.0000000000000531","volume":"29","author":"JR Kelsen","year":"2017","unstructured":"Kelsen JR, Baldassano RN. The role of monogenic disease in children with very early onset inflammatory bowel disease. Curr Opin Pediatr. 2017;29(5):566\u201371. https:\/\/doi.org\/10.1097\/MOP.0000000000000531.","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"279_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5223\/pghn.2019.22.1.41","volume":"22","author":"JO Shim","year":"2019","unstructured":"Shim JO. Recent advance in very early onset inflammatory bowel disease. Pediatr Gastroenterol Hepatol Nutr. 2019;22(1):41\u20139. https:\/\/doi.org\/10.5223\/pghn.2019.22.1.41.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"279_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-12-800267-4.00005-5.Interleukin","volume":"122","author":"DS Shouval","year":"2016","unstructured":"Shouval DS, Ouahed J, Biswas A, et al. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans Dror. Adv Immunol. 2016;122:177\u2013210. https:\/\/doi.org\/10.1016\/B978-0-12-800267-4.00005-5.Interleukin.","journal-title":"Adv Immunol"},{"key":"279_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-3-662-43492-5","volume":"380","author":"MR Walter","year":"2014","unstructured":"Walter MR. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol. 2014;380:191\u2013212. https:\/\/doi.org\/10.1007\/978-3-662-43492-5.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"25","key":"279_CR8","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.3748\/wjg.v19.i25.3931","volume":"19","author":"GJ Marlow","year":"2013","unstructured":"Marlow GJ, Van GD, Ferguson LR, et al. Why interleukin-10 supplementation does not work in Crohn \u2019 s disease patients. World J Gastroenterol. 2013;19(25):3931\u201341. https:\/\/doi.org\/10.3748\/wjg.v19.i25.3931.","journal-title":"World J Gastroenterol"},{"key":"279_CR9","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.2174\/1381612043382602","volume":"10","author":"A Zdanov","year":"2004","unstructured":"Zdanov A. Structural features of the Interleukin-10 family of cytokines. Curr Pharm Des. 2004;10:3873\u201384.","journal-title":"Curr Pharm Des"},{"key":"279_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11882-012-0286-z","volume":"12","author":"N Shah","year":"2012","unstructured":"Shah N, Kammermeier J, Elawad M. Interleukin-10 and Interleukin-10 \u2013 receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep. 2012;12:373\u20139. https:\/\/doi.org\/10.1007\/s11882-012-0286-z.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"279_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14740\/gr740w","volume":"10","author":"L Zhu","year":"2017","unstructured":"Zhu L, Shi T, Zhong C, Wang Y, Chang M, Liu X. IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease. Gastroenterol Res. 2017;10(2):65\u20139.","journal-title":"Gastroenterol Res"},{"key":"279_CR12","first-page":"1","volume-title":"Current topics in microbiology and immunology Interleukin-10 in health and disease","author":"KR Engelhardt","year":"2014","unstructured":"Engelhardt KR, Grimbacher B. IL-10 in humans: lessons from the gut, IL-10\/IL-10 receptor deficiencies, and IL-10 polymorphisms. In: Current topics in microbiology and immunology Interleukin-10 in health and disease; 2014. p. 1\u201318."},{"issue":"1","key":"279_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26717\/BJSTR.2018.02.000713","volume":"2","author":"Z Lin","year":"2018","unstructured":"Lin Z, Sci BJ, Res T, Lin TR, Floros J, Lin Z. Pediatric inflammatory bowel Disease\u00a0: a review of immune homeostasis and genetics with an emphasis on the IL-10 pathway. J Sci Tech Res. 2018;2(1):1\u20139. https:\/\/doi.org\/10.26717\/BJSTR.2018.02.000713.","journal-title":"J Sci Tech Res"},{"issue":"4","key":"279_CR14","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1182\/blood-2003-12-4302","volume":"104","author":"S Bhattacharyya","year":"2004","unstructured":"Bhattacharyya S, Sen P, Wallet M, Long B, Baldwin ASJ, Tisch R. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K\/Akt pathway and of IkappaB kinase activity. Blood. 2004;104(4):1100\u20139. https:\/\/doi.org\/10.1182\/blood-2003-12-4302.","journal-title":"Blood."},{"issue":"43","key":"279_CR15","doi-asserted-by":"publisher","first-page":"18327","DOI":"10.1073\/pnas.0905815106","volume":"106","author":"J Chang","year":"2009","unstructured":"Chang J, Kunkel SL, Chang C-H. Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci U S A. 2009;106(43):18327\u201332. https:\/\/doi.org\/10.1073\/pnas.0905815106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"279_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2362.2011.02552.x","volume":"42","author":"G Paul","year":"2011","unstructured":"Paul G, Khare V, Gasche C. Inflamed gut mucosa\u00a0: downstream of interleukin-10. Eur J Clin Investig. 2011;42(1):95\u2013109. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02552.x.","journal-title":"Eur J Clin Investig"},{"issue":"8","key":"279_CR17","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1097\/MIB.0000000000000468","volume":"21","author":"LM Keubler","year":"2015","unstructured":"Keubler LM, Buettner M, H\u00e4ger C, Bleich A. A multihit model: colitis lessons from the Interleukin-10-deficient mouse. Inflamm Bowel Dis. 2015;21(8):1967\u201375. https:\/\/doi.org\/10.1097\/MIB.0000000000000468.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"279_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32(1):23\u201363.","journal-title":"Crit Rev Immunol"},{"issue":"2","key":"279_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cyto.2014.11.002","volume":"73","author":"MJ Cho","year":"2015","unstructured":"Cho MJ, Ellebrecht CT, Payne AS. The dual nature of interleukin-10 in pemphigus vulgaris. Cytokine. 2015;73(2):335\u201341. https:\/\/doi.org\/10.1016\/j.cyto.2014.11.002.","journal-title":"Cytokine"},{"issue":"2","key":"279_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","volume":"75","author":"R Kuhn","year":"1993","unstructured":"Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75(2):263\u201374.","journal-title":"Cell."},{"issue":"4","key":"279_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1084\/jem.187.4.571","volume":"187","author":"SD Spencer","year":"1998","unstructured":"Spencer SD, Di Marco F, Hooley J, et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med. 1998;187(4):571\u20138.","journal-title":"J Exp Med"},{"issue":"11","key":"279_CR22","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1128\/IAI.66.11.5224-5231.1998","volume":"66","author":"RK Sellon","year":"1998","unstructured":"Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66(11):5224\u201331.","journal-title":"Infect Immun"},{"issue":"4","key":"279_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2005.02.009","volume":"128","author":"SC Kim","year":"2005","unstructured":"Kim SC, Tonkonogy SL, Albright CA, et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology. 2005;128(4):891\u2013906.","journal-title":"Gastroenterology."},{"issue":"3","key":"279_CR24","doi-asserted-by":"publisher","first-page":"G764","DOI":"10.1152\/ajpgi.2001.281.3.G764","volume":"281","author":"A Burich","year":"2001","unstructured":"Burich A, Hershberg R, Waggie K, et al. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2001;281(3):G764\u201378. https:\/\/doi.org\/10.1152\/ajpgi.2001.281.3.G764.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"279_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ibd.21895","volume":"18","author":"G Buchler","year":"2012","unstructured":"Buchler G, Wos-Oxley ML, Smoczek A, et al. Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host interactions. Inflamm Bowel Dis. 2012;18(5):943\u201354. https:\/\/doi.org\/10.1002\/ibd.21895.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"279_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/01.MIB.0000441346.86827.ed","volume":"20","author":"M Basic","year":"2014","unstructured":"Basic M, Keubler LM, Buettner M, et al. Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflamm Bowel Dis. 2014;20(3):431\u201343. https:\/\/doi.org\/10.1097\/01.MIB.0000441346.86827.ed.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"279_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/gut.52.7.975","volume":"52","author":"J McCarthy","year":"2003","unstructured":"McCarthy J, O\u2019Mahony L, O\u2019Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003;52(7):975\u201380. https:\/\/doi.org\/10.1136\/gut.52.7.975.","journal-title":"Gut."},{"key":"279_CR28","doi-asserted-by":"publisher","first-page":"560817","DOI":"10.1155\/2012\/560817","volume":"2012","author":"AC Gomes-Santos","year":"2012","unstructured":"Gomes-Santos AC, Moreira TG, Castro-Junior AB, et al. New insights into the immunological changes in IL-10-deficient mice during the course of spontaneous inflammation in the gut mucosa. Clin Dev Immunol. 2012;2012:560817. https:\/\/doi.org\/10.1155\/2012\/560817.","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"279_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1749-6632.2011.06339.x","volume":"1246","author":"E-O Glocker","year":"2011","unstructured":"Glocker E-O, Kotlarz D, Klein C, Shah N, Grimbacher B. IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci. 2011;1246(1):102\u20137. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06339.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"279_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.gastro.2012.04.045","volume":"143","author":"D Kotlarz","year":"2012","unstructured":"Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143(2):347\u201355. https:\/\/doi.org\/10.1053\/j.gastro.2012.04.045.","journal-title":"Gastroenterology."},{"issue":"1","key":"279_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/ecco-jcc\/jjw118","volume":"11","author":"J Kammermeier","year":"2017","unstructured":"Kammermeier J, Dziubak R, Pescarin M, et al. Phenotypic and genotypic characterisation of inflammatory bowel disease presenting before the age of 2 years. J Crohns Colitis. 2017;11(1):60\u20139. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw118.","journal-title":"J Crohns Colitis"},{"issue":"13","key":"279_CR32","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1097\/01.MIB.0000435439.22484.d3","volume":"19","author":"B Pigneur","year":"2013","unstructured":"Pigneur B, Escher J, Elawad M, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the genius working group. Inflamm Bowel Dis. 2013;19(13):2820\u20138. https:\/\/doi.org\/10.1097\/01.MIB.0000435439.22484.d3.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"279_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","volume":"131","author":"KR Engelhardt","year":"2013","unstructured":"Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10\u2013 and IL-10 receptor\u2013deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131(3):825\u2013830.e9. https:\/\/doi.org\/10.1016\/j.jaci.2012.09.025.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"279_CR34","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation. Immunity. 2019;50(4):871\u201391. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.020.","journal-title":"Immunity"},{"issue":"2","key":"279_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/gast.1997.v113.pm9247454","volume":"113","author":"SJ van Deventer","year":"1997","unstructured":"van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn\u2019s disease. Crohn\u2019s disease study group. Gastroenterology. 1997;113(2):383\u20139.","journal-title":"Gastroenterology."},{"issue":"6","key":"279_CR36","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1053\/gast.2000.20229","volume":"119","author":"RN Fedorak","year":"2000","unstructured":"Fedorak RN, Gangl A, Elson CO, et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn\u2019s disease. The interleukin 10 inflammatory bowel disease cooperative study group. Gastroenterology. 2000;119(6):1473\u201382.","journal-title":"Gastroenterology."},{"key":"279_CR37","doi-asserted-by":"publisher","first-page":"CD005109","DOI":"10.1002\/14651858.CD005109.pub3","volume":"11","author":"FE Buruiana","year":"2010","unstructured":"Buruiana FE, Sola I, Alonso-Coello P. Recombinant human interleukin 10 for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev. 2010;11:CD005109. https:\/\/doi.org\/10.1002\/14651858.CD005109.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"279_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ajgsup.2016.18","volume":"3","author":"J Bilsborough","year":"2016","unstructured":"Bilsborough J, Targan SR, Snapper SB. Therapeutic targets in inflammatory bowel disease: current and future. Am J Gastroenterol Suppl. 2016;3:37.","journal-title":"Am J Gastroenterol Suppl"}],"container-title":["Journal of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-021-00279-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12950-021-00279-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-021-00279-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T13:11:55Z","timestamp":1615381915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal-inflammation.biomedcentral.com\/articles\/10.1186\/s12950-021-00279-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1186\/s12950-021-00279-3","relation":{},"ISSN":["1476-9255"],"issn-type":[{"value":"1476-9255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"10 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}